Ceva Sante Animale opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ceva Sante Animale

Patent Number:
Title:
Treatment Of Metabolic Disorders In Canine Animals
Opposition Date:
Feb 9, 2024
Patent Number:
Title:
A Vaccine For Protection Against Streptococcus Suis
Opposition Date:
Sep 19, 2023
Patent Number:
Title:
Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine
Opposition Date:
Jul 26, 2023
Patent Number:
Title:
Isoxazoline Compositions And Their Use As Antiparasitics For Felines
Opposition Date:
Feb 11, 2022
Patent Number:
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them
Opposition Date:
Dec 2, 2021
Patent Number:
Title:
Vaccine For Protection Against Lawsonia Intracellularis
Opposition Date:
May 4, 2021
Patent Number:
Title:
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs
Opposition Date:
Apr 27, 2021
Patent Number:
Title:
A Vaccine For Use Against Subclinical Lawsonia Infection In A Pig
Opposition Date:
Feb 5, 2021
Patent Number:
Title:
A Vaccine For Use Against Subclinical Lawsonia Infection In A Pig
Opposition Date:
Feb 5, 2021
Patent Number:
Title:
Isoxazoline Compositions And Their Use As Antiparasitics
Opposition Date:
Dec 11, 2020

Latest patents of Ceva Sante Animale opposed by its competitors

Patent:
Grant Date:
Mar 27, 2019
Title:
Recombinant Marek'S Disease Viruses And Uses Thereof
Oppositions:
1
Patent:
Grant Date:
Oct 4, 2017
Title:
Synthetic Capsid Proteins And Uses Thereof
Oppositions:
1
Patent:
Grant Date:
May 3, 2017
Title:
Multivalent Recombinant Avian Herpes Viruses And Vaccines For Immunizing Avian Species
Oppositions:
1

Want to track Ceva Sante Animale?

Feel free to send us a message here and we will get back to you